A citation-based method for searching scientific literature

Beate Fiedler, Suzanne M Lohmann, Albert Smolenski, Stephan Linnemuller, Burkert Pieske, Frank Schroder, Jeffery D Molkentin, Helmut Drexler, Kai C Wollert. Proc Natl Acad Sci U S A 2002
Times Cited: 203







List of co-cited articles
1127 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Eiki Takimoto, Hunter C Champion, Manxiang Li, Diego Belardi, Shuxun Ren, E Rene Rodriguez, Djahida Bedja, Kathleen L Gabrielson, Yibin Wang, David A Kass. Nat Med 2005
684
37

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
J D Molkentin, J R Lu, C L Antos, B Markham, J Richardson, J Robbins, S R Grant, E N Olson. Cell 1998
21


Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.
Kai C Wollert, Beate Fiedler, Stepan Gambaryan, Albert Smolenski, Jörg Heineke, Elke Butt, Christian Trautwein, Suzanne M Lohmann, Helmut Drexler. Hypertension 2002
114
20

Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
Norimichi Koitabashi, Takeshi Aiba, Geoffrey G Hesketh, Janelle Rowell, Manling Zhang, Eiki Takimoto, Gordon F Tomaselli, David A Kass. J Mol Cell Cardiol 2010
125
20


Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.
Eiki Takimoto, Norimichi Koitabashi, Steven Hsu, Elizabeth A Ketner, Manling Zhang, Takahiro Nagayama, Djahida Bedja, Kathleen L Gabrielson, Robert Blanton, David P Siderovski,[...]. J Clin Invest 2009
160
17

Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs.
Martina Krüger, Sebastian Kötter, Anika Grützner, Patrick Lang, Christian Andresen, Margaret M Redfield, Elke Butt, Cris G dos Remedios, Wolfgang A Linke. Circ Res 2009
288
16

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.
Koichiro Kuwahara, Yanggan Wang, John McAnally, James A Richardson, Rhonda Bassel-Duby, Joseph A Hill, Eric N Olson. J Clin Invest 2006
395
15

Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Takeshi Tokudome, Ichiro Kishimoto, Takeshi Horio, Yuji Arai, Daryl O Schwenke, Jun Hino, Ichiro Okano, Yuhei Kawano, Masakazu Kohno, Mikiya Miyazato,[...]. Circulation 2008
80
18

Regulation of cardiac hypertrophy by intracellular signalling pathways.
Joerg Heineke, Jeffery D Molkentin. Nat Rev Mol Cell Biol 2006
15

Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Rita Holtwick, Martin van Eickels, Boris V Skryabin, Hideo A Baba, Alexander Bubikat, Frank Begrow, Michael D Schneider, David L Garbers, Michaela Kuhn. J Clin Invest 2003
281
14

Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.
Peter Pokreisz, Sara Vandenwijngaert, Virginie Bito, An Van den Bergh, Ilse Lenaerts, Cornelius Busch, Glenn Marsboom, Olivier Gheysens, Pieter Vermeersch, Liesbeth Biesmans,[...]. Circulation 2009
140
14


Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Margaret M Redfield, Horng H Chen, Barry A Borlaug, Marc J Semigran, Kerry L Lee, Gregory Lewis, Martin M LeWinter, Jean L Rouleau, David A Bull, Douglas L Mann,[...]. JAMA 2013
777
13

Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
Steven Hsu, Takahiro Nagayama, Norimichi Koitabashi, Manling Zhang, Liye Zhou, Djahida Bedja, Kathleen L Gabrielson, Jeffery D Molkentin, David A Kass, Eiki Takimoto. Cardiovasc Res 2009
45
26

Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits.
Lin Yang, Guoxia Liu, Sergey I Zakharov, Andrew M Bellinger, Marco Mongillo, Steven O Marx. Circ Res 2007
87
13

Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.
Eiki Takimoto, Hunter C Champion, Manxiang Li, Shuxun Ren, E Rene Rodriguez, Barbara Tavazzi, Giuseppe Lazzarino, Nazareno Paolocci, Kathleen L Gabrielson, Yibin Wang,[...]. J Clin Invest 2005
351
12

TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
Naoya Onohara, Motohiro Nishida, Ryuji Inoue, Hiroyuki Kobayashi, Hideki Sumimoto, Yoji Sato, Yasuo Mori, Taku Nagao, Hitoshi Kurose. EMBO J 2006
301
11




Defective smooth muscle regulation in cGMP kinase I-deficient mice.
A Pfeifer, P Klatt, S Massberg, L Ny, M Sausbier, C Hirneiss, G X Wang, M Korth, A Aszódi, K E Andersson,[...]. EMBO J 1998
425
11


Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes.
Robert Lukowski, Sergei D Rybalkin, Florian Loga, Veronika Leiss, Joseph A Beavo, Franz Hofmann. Proc Natl Acad Sci U S A 2010
82
13

Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5.
Manling Zhang, Eiki Takimoto, Steven Hsu, Dong I Lee, Takahiro Nagayama, Thomas Danner, Norimichi Koitabashi, Andreas S Barth, Djahida Bedja, Kathleen L Gabrielson,[...]. J Am Coll Cardiol 2010
60
18

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
Loek van Heerebeek, Nazha Hamdani, Inês Falcão-Pires, Adelino F Leite-Moreira, Mark P V Begieneman, Jean G F Bronzwaer, Jolanda van der Velden, Ger J M Stienen, Gerrit J Laarman, Aernout Somsen,[...]. Circulation 2012
297
11

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
Dong I Lee, Guangshuo Zhu, Takashi Sasaki, Gun-Sik Cho, Nazha Hamdani, Ronald Holewinski, Su-Hyun Jo, Thomas Danner, Manling Zhang, Peter P Rainer,[...]. Nature 2015
205
11

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.
D Levy, R J Garrison, D D Savage, W B Kannel, W P Castelli. N Engl J Med 1990
10

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
Christopher L Antos, Timothy A McKinsey, Norbert Frey, William Kutschke, John McAnally, John M Shelton, James A Richardson, Joseph A Hill, Eric N Olson. Proc Natl Acad Sci U S A 2002
382
10

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.
P M Oliver, J E Fox, R Kim, H A Rockman, H S Kim, R L Reddick, K N Pandey, S L Milgram, O Smithies, N Maeda. Proc Natl Acad Sci U S A 1997
463
10

Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice.
Frank Schröder, Gunnar Klein, Beate Fiedler, Michaela Bastein, Nicole Schnasse, Anja Hillmer, Sandra Ames, Stepan Gambaryan, Helmut Drexler, Ulrich Walter,[...]. Cardiovasc Res 2003
59
16

Nitric oxide signaling and the regulation of myocardial function.
Mark T Ziolo, Mark J Kohr, Honglan Wang. J Mol Cell Cardiol 2008
97
10

Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
Motohiro Nishida, Kenta Watanabe, Yoji Sato, Michio Nakaya, Naoyuki Kitajima, Tomomi Ide, Ryuji Inoue, Hitoshi Kurose. J Biol Chem 2010
76
13

Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
Marco Mongillo, Carlo G Tocchetti, Anna Terrin, Valentina Lissandron, York-Fong Cheung, Wolfgang R Dostmann, Tullio Pozzan, David A Kass, Nazareno Paolocci, Miles D Houslay,[...]. Circ Res 2006
217
10

Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.
Kalkidan Bishu, Nazha Hamdani, Selma F Mohammed, Martina Kruger, Tomohito Ohtani, Ozgur Ogut, Frank V Brozovich, John C Burnett, Wolfgang A Linke, Margaret M Redfield. Circulation 2011
129
10

Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
Stefan Frantz, Michael Klaiber, Hideo A Baba, Heike Oberwinkler, Katharina Völker, Birgit Gaβner, Barbara Bayer, Marco Abeβer, Kai Schuh, Robert Feil,[...]. Eur Heart J 2013
73
13

Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes.
Manling Zhang, Norimichi Koitabashi, Takahiro Nagayama, Ryan Rambaran, Ning Feng, Eiki Takimoto, Trisha Koenke, Brian O'Rourke, Hunter C Champion, Michael T Crow,[...]. Cell Signal 2008
72
12

p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload.
Masanori Sano, Tohru Minamino, Haruhiro Toko, Hideyuki Miyauchi, Masayuki Orimo, Yingjie Qin, Hiroshi Akazawa, Kaoru Tateno, Yosuke Kayama, Mutsuo Harada,[...]. Nature 2007
661
9


The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.
Johannes Backs, Thea Backs, Stefan Neef, Michael M Kreusser, Lorenz H Lehmann, David M Patrick, Chad E Grueter, Xiaoxia Qi, James A Richardson, Joseph A Hill,[...]. Proc Natl Acad Sci U S A 2009
305
9

Protein kinase cascades in the regulation of cardiac hypertrophy.
Gerald W Dorn, Thomas Force. J Clin Invest 2005
484
9

cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium.
Jörg W Wegener, Hermann Nawrath, Wiebke Wolfsgruber, Susanne Kühbandner, Claudia Werner, Franz Hofmann, Robert Feil. Circ Res 2002
140
9

cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Eiki Takimoto, Hunter C Champion, Diego Belardi, Javid Moslehi, Marco Mongillo, Evanthia Mergia, David C Montrose, Takayoshi Isoda, Kate Aufiero, Manuela Zaccolo,[...]. Circ Res 2005
160
9

Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
J W Knowles, G Esposito, L Mao, J R Hagaman, J E Fox, O Smithies, H A Rockman, N Maeda. J Clin Invest 2001
230
9

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
Jayan Nagendran, Stephen L Archer, Daniel Soliman, Vikram Gurtu, Rohit Moudgil, Alois Haromy, Chantal St Aubin, Linda Webster, Ivan M Rebeyka, David B Ross,[...]. Circulation 2007
377
9

PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
Dong I Lee, Susan Vahebi, Carlo Gabriele Tocchetti, Lili A Barouch, R John Solaro, Eiki Takimoto, David A Kass. Basic Res Cardiol 2010
78
11

Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
Clint L Miller, Masayoshi Oikawa, Yujun Cai, Andrew P Wojtovich, David J Nagel, Xiangbin Xu, Haodong Xu, Vince Florio, Sergei D Rybalkin, Joseph A Beavo,[...]. Circ Res 2009
127
9

Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.
Liliana R V Castro, Ignacio Verde, Dermot M F Cooper, Rodolphe Fischmeister. Circulation 2006
207
9

Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart.
Hiroyuki Nakayama, Benjamin J Wilkin, Ilona Bodi, Jeffery D Molkentin. FASEB J 2006
212
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.